Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Immunotherapy biomarkers

Original research

Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma

Online download statistics by month:

Online download statistics by month: July 2021 to March 2024

	Abstract	Full	Pdf
Jul 2021	871	878	273
Aug 2021	396	395	142
Sep 2021	315	315	127
Oct 2021	434	434	72
Nov 2021	350	351	60
Dec 2021	466	469	76
Jan 2022	173	177	50
Feb 2022	133	134	38
Mar 2022	109	118	53
Apr 2022	82	87	36
May 2022	88	90	41
Jun 2022	99	108	32
Jul 2022	148	150	41
Aug 2022	154	158	60
Sep 2022	147	148	50
Oct 2022	157	164	62
Nov 2022	124	124	25
Dec 2022	138	138	27
Jan 2023	123	123	27
Feb 2023	149	149	40
Mar 2023	114	115	36
Apr 2023	98	98	20
May 2023	96	96	18
Jun 2023	93	95	16
Jul 2023	107	107	48
Aug 2023	104	104	23
Sep 2023	109	112	19
Oct 2023	101	101	17
Nov 2023	95	95	23
Dec 2023	100	101	22
Jan 2024	60	61	29
Feb 2024	71	73	31
Mar 2024	113	113	63
Total	5917	5981	1697